[go: up one dir, main page]

FI922268L - Förfarande för framställning av nya terapeutiskt användbara N-difenylalkylalkoxisubstituerade 3-piperidinkarboxylsyraderivat - Google Patents

Förfarande för framställning av nya terapeutiskt användbara N-difenylalkylalkoxisubstituerade 3-piperidinkarboxylsyraderivat Download PDF

Info

Publication number
FI922268L
FI922268L FI922268A FI922268A FI922268L FI 922268 L FI922268 L FI 922268L FI 922268 A FI922268 A FI 922268A FI 922268 A FI922268 A FI 922268A FI 922268 L FI922268 L FI 922268L
Authority
FI
Finland
Prior art keywords
diphenylalkylalkoxy
substituted
preparation
acid derivatives
therapeutically useful
Prior art date
Application number
FI922268A
Other languages
English (en)
Finnish (fi)
Other versions
FI922268A0 (sv
FI97541B (sv
FI97541C (sv
Inventor
Knud Erik Andersen
Lars Jacob Stray Knudsen
Ursula Sonnewald
Per Olaf Soerensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI922268A0 publication Critical patent/FI922268A0/sv
Publication of FI922268L publication Critical patent/FI922268L/sv
Publication of FI97541B publication Critical patent/FI97541B/sv
Application granted granted Critical
Publication of FI97541C publication Critical patent/FI97541C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
FI922268A 1989-11-22 1992-05-19 Förfarande för framställning av nya terapeutiskt användbara N-difenylalkylalkoxisubstituerade 3-piperidinkarboxylsyraderivat FI97541C (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK588189 1989-11-22
DK588189A DK588189D0 (da) 1989-11-22 1989-11-22 Nye heterocykliske carboxylsyrer
DK9000302 1990-11-22
PCT/DK1990/000302 WO1991007389A1 (en) 1989-11-22 1990-11-22 N-substituted azaheterocyclic carboxylic acids and a pharmaceutical composition

Publications (4)

Publication Number Publication Date
FI922268A0 FI922268A0 (sv) 1992-05-19
FI922268L true FI922268L (sv) 1992-05-19
FI97541B FI97541B (sv) 1996-09-30
FI97541C FI97541C (sv) 1997-01-10

Family

ID=8145900

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922268A FI97541C (sv) 1989-11-22 1992-05-19 Förfarande för framställning av nya terapeutiskt användbara N-difenylalkylalkoxisubstituerade 3-piperidinkarboxylsyraderivat

Country Status (16)

Country Link
US (1) US5198451A (sv)
EP (1) EP0502031B1 (sv)
JP (1) JPH05503083A (sv)
AT (1) ATE157086T1 (sv)
AU (1) AU660919B2 (sv)
CA (1) CA2073189C (sv)
DE (1) DE69031312T2 (sv)
DK (2) DK588189D0 (sv)
FI (1) FI97541C (sv)
IE (1) IE904155A1 (sv)
IL (2) IL96370A (sv)
NO (1) NO177853C (sv)
NZ (1) NZ236155A (sv)
PT (1) PT95970B (sv)
WO (1) WO1991007389A1 (sv)
ZA (1) ZA909305B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK74693D0 (da) * 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
US5962449A (en) 1995-04-07 1999-10-05 Novo Nordisk A/S Tricyclic compounds in treating hyperalgesic conditions and NIDDM
ES2297859T3 (es) * 1996-05-24 2008-05-01 Smithkline Beecham Corporation Uso de inhibidores de la captacion de gaba como agentes antitusivos.
DE10204496A1 (de) * 2002-02-04 2003-08-21 Msa Auer Gmbh Vorrichtung zur Dosierung gas- und/oder dampfförmiger Stoffe

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383999A (en) * 1981-05-26 1983-05-17 Smithkline Beckman Corporation Inhibition of GABA uptake by N-substituted azaheterocyclic carboxylic acids and their esters
DK704488D0 (da) * 1988-12-19 1988-12-19 Novo Industri As Nye n-substituerede azaheterocykliske carboxylsyrer
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
US4910312A (en) * 1985-11-08 1990-03-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
FI864246A (fi) * 1985-11-08 1987-05-09 Warner Lambert Co N-substituerade 3-piperidin- eller 3-pyridinkarboxylsyror samt deras derivat.
US4772615A (en) * 1985-11-08 1988-09-20 Warner-Lambert Company Various N-substituted 3-piperidine carboxylic acids or N-substituted 3-pyridinecarboxylic acids and derivatives thereof
ES2059360T3 (es) * 1986-01-07 1994-11-16 Novo Nordisk As Nuevos derivados de aminoacidos.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents

Also Published As

Publication number Publication date
NO177853C (no) 1995-12-06
CA2073189A1 (en) 1991-05-23
NO921852L (no) 1992-05-11
DE69031312T2 (de) 1998-02-26
US5198451A (en) 1993-03-30
PT95970B (pt) 1998-01-30
AU6746490A (en) 1991-06-13
IL96370A0 (en) 1991-08-16
IL96370A (en) 1995-01-24
DK588189D0 (da) 1989-11-22
NO921852D0 (no) 1992-05-11
CA2073189C (en) 1998-04-07
FI922268A0 (sv) 1992-05-19
IE904155A1 (en) 1991-05-22
FI97541B (sv) 1996-09-30
JPH05503083A (ja) 1993-05-27
AU660919B2 (en) 1995-07-13
EP0502031B1 (en) 1997-08-20
DE69031312D1 (de) 1997-09-25
EP0502031A1 (en) 1992-09-09
PT95970A (pt) 1991-09-13
WO1991007389A1 (en) 1991-05-30
FI97541C (sv) 1997-01-10
ATE157086T1 (de) 1997-09-15
ZA909305B (en) 1991-09-25
NZ236155A (en) 1993-04-28
NO177853B (no) 1995-08-28
DK0502031T3 (da) 1998-03-30

Similar Documents

Publication Publication Date Title
FI875660L (sv) Förfarande för framställning av terapeutiskt användbara 5-fenyl-2-pyrimidinonderivat
FI914905L (sv) Förfarande för framställning av nya terapeutiskt användbara merkaptoacetylamidopyrrolo- och -pyridobensazepinderivat
PT87754A (pt) Process for the preparation of new amino acid derivatives
FI905941A (sv) Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat
FI96861C (sv) Förfarande för framställning av terapeutiskt aktiva substituerade indolylpyrrolderivat
FI890508L (sv) Förfarande för framställning av farmaceutiskt aktiva 3-indolpyrodruvsyraderivat
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
PT86687A (pt) Process for the preparation of novel polyamine derivatives
FI923527L (sv) Förfarande för framställning av terapeutiskt användbara 3-piperidino-4-hydroxikromanderivat
FI906408L (sv) Förfarande för framställning av terapeutiskt användbara 2-aminopyrimidin-4-karboxamidderivat
PT87153A (pt) Process for the preparation of acid ribofuranuronic derivatives
FI883997A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 2-fenyl-4-kinolinkarboxylsyror
FI895393A0 (sv) Förfarande för framställning av terapeutiskt användbara alkylsubstituerade-2-alkylaminbensopyran-6-oler
FI883672A (sv) Förfarande för framställning av terapeutiskt användbara aminoalkoxifenylderivat
FI880467A0 (sv) Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner
FI93444B (sv) Förfarande för framställning av terapeutiskt aktiva dihydropyridinföreningar
FI871087A0 (sv) Förfarande för framställning av terapeutiskt användbara 1,2,3,4-tetrahydro-3-karbamoyl-2-tioxo/oxo-5-pyrimidinkarboxylsyraderivat
FI882002L (sv) Förfarande för framställning av terapeutiskt aktiva fenylpiperidinderivat
FI890723A (sv) Förfarande för framställning av kinolinkarboxylsyraderivat
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
PT88545A (pt) Process for the manufacture of benzimidazoline-2-oxo-1-carboxylic acid derivative compounds
FI884473A (sv) Förfarande för framställning av terapeutiskt användbara fenoxialkylpyrokatekolderivat
FI900145L (sv) Förfarande för framställning av farmaceutiskt användbara 1,1-dioxo-cefem-4-karbotiolsyraderivat
FI893682L (sv) Förfarande för framställning av en terapeutiskt användbar 1,2,5-ditiazocinderivat
PT88432A (pt) Process for the preparation of 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents

Legal Events

Date Code Title Description
BB Publication of examined application